BioNeutra Global Statistics
Total Valuation
BGACF has a market cap or net worth of 1.01 million. The enterprise value is 5.91 million.
| Market Cap | 1.01M |
| Enterprise Value | 5.91M |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.45M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 29.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | -0.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.08 |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.93 |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -13.16 |
| Interest Coverage | -1.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.43% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 49.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.68% in the last 52 weeks. The beta is 0.85, so BGACF's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -90.68% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.47 |
| Average Volume (20 Days) | 4,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BGACF had revenue of 8.04 million and -451,686 in losses. Loss per share was -0.01.
| Revenue | 8.04M |
| Gross Profit | 3.44M |
| Operating Income | -597,200 |
| Pretax Income | -451,686 |
| Net Income | -451,686 |
| EBITDA | -258,718 |
| EBIT | -597,200 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 589,615 in cash and 5.58 million in debt, giving a net cash position of -4.99 million.
| Cash & Cash Equivalents | 589,615 |
| Total Debt | 5.58M |
| Net Cash | -4.99M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.09M |
| Book Value Per Share | -0.13 |
| Working Capital | -7.35M |
Cash Flow
In the last 12 months, operating cash flow was -370,482 and capital expenditures -53,642, giving a free cash flow of -424,124.
| Operating Cash Flow | -370,482 |
| Capital Expenditures | -53,642 |
| Free Cash Flow | -424,124 |
| FCF Per Share | n/a |
Margins
Gross margin is 42.84%, with operating and profit margins of -7.43% and -5.62%.
| Gross Margin | 42.84% |
| Operating Margin | -7.43% |
| Pretax Margin | -5.62% |
| Profit Margin | -5.62% |
| EBITDA Margin | -3.22% |
| EBIT Margin | -7.43% |
| FCF Margin | n/a |
Dividends & Yields
BGACF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -44.66% |
| FCF Yield | -41.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BGACF has an Altman Z-Score of -2.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.05 |
| Piotroski F-Score | 3 |